0000950170-24-009160.txt : 20240131 0000950170-24-009160.hdr.sgml : 20240131 20240131090041 ACCESSION NUMBER: 0000950170-24-009160 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20240130 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240131 DATE AS OF CHANGE: 20240131 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Heart Test Laboratories, Inc. CENTRAL INDEX KEY: 0001468492 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 261344466 STATE OF INCORPORATION: TX FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41422 FILM NUMBER: 24580772 BUSINESS ADDRESS: STREET 1: 550 RESERVE ST, SUITE 360 CITY: SOUTHLAKE STATE: TX ZIP: 76092 BUSINESS PHONE: 682-237-7781 MAIL ADDRESS: STREET 1: 550 RESERVE ST, SUITE 360 CITY: SOUTHLAKE STATE: TX ZIP: 76092 8-K 1 hscs-20240130.htm 8-K 8-K
false00014684920001468492us-gaap:WarrantMember2024-01-302024-01-3000014684922024-01-302024-01-300001468492us-gaap:CommonStockMember2024-01-302024-01-30

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 30, 2024

 

 

Heart Test Laboratories, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Texas

001-41422

26-1344466

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

550 Reserve Street, Suite 360

 

Southlake, Texas

 

76092

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 682 237-7781

 

n/a

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock

 

HSCS

 

The Nasdaq Stock Market LLC

Warrants

 

HSCSW

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 

 

 

 

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

As previously reported, on August 2, 2023, Heart Test Laboratories, Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of our common stock, $0.001 par value per share (“Common Stock”) for the previous 30 consecutive business days, we no longer met the requirement to maintain a minimum bid price of $1 per share (the “Minimum Bid Price Requirement”) and were required to regain compliance with the Minimum Bid Price Requirement by January 29, 2024.

On January 30, 2024, the Company received a letter from Nasdaq advising that the Company had been granted an additional 180-day extension to July 29, 2024, to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A).

If the Company does not regain compliance within the allotted compliance period, Nasdaq staff will provide notice that the Company’s Common Stock will be subject to delisting. The Company would then be entitled to appeal that determination to a Nasdaq hearings panel. The Company will continue to monitor the closing bid price of its Common Stock and may, if necessary, implement a reverse stock split of its outstanding securities, to regain compliance with the Minimum Bid Price Requirement. There can be no assurance that the Company will regain compliance with the Minimum Bid Price Requirement during this 180-day extension.

Statements contained herein relating to the Company or its management’s intentions, hopes, beliefs, expectations or predictions of the future, including, but not limited to, statements relating to the Company’s ability to regain compliance with the Nasdaq continued listing standards constitute forward looking statements. Such forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to, risks related to the Company’s ability to regain compliance with the Nasdaq continued listing standards. Additional risks and uncertainties faced by the Company are contained from time to time in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, the Company’s Annual Report on Form 10-K for the year ended April 30, 2023 filed with the Securities and Exchange Commission on July 19, 2023. The Company disclaims any intention or obligation to update, amend or clarify these forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.

Description

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)



 

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

HEART TEST LABORATORIES, INC.

 

 

 

 

Date:

January 31, 2024

By:

/s/ Andrew Simpson

 

 

Name:

Title:

Andrew Simpson
President, Chief Executive Officer, and Chairman of the Board of Directors
 

 

 

 EX-101.SCH 2 hscs-20240130.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink Document Information [Table] Document Information Pre-commencement Issuer Tender Offer Entity Address, State or Province Trading Symbol Soliciting Material Entity Address, City or Town Written Communications Class of Stock [Domain] Entity Central Index Key CIK Entity Tax Identification Number Entity Registrant Name Registrant Name Class of Stock [Axis] Entity Ex Transition Period Entity Information, Former Legal or Registered Name Document Period End Date Period End Date Entity Address, Postal Zip Code Entity Incorporation, State or Country Code Local Phone Number City Area Code Document Information [Line Items] Document Information: Warrant [Member] Common Stock [Member] Pre-commencement Tender Offer Cover [Abstract] Cover Security Exchange Name Entity Emerging Growth Company Amendment Flag Amendment Entity File Number Entity Address, Address Line One Title of 12(b) Security Document Type Document Type XML 3 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document And Entity Information
Jan. 30, 2024
Document Information [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 30, 2024
Entity Registrant Name Heart Test Laboratories, Inc.
Entity Central Index Key 0001468492
Entity Emerging Growth Company true
Entity File Number 001-41422
Entity Incorporation, State or Country Code TX
Entity Tax Identification Number 26-1344466
Entity Address, Address Line One 550 Reserve Street, Suite 360
Entity Address, City or Town Southlake
Entity Address, State or Province TX
Entity Address, Postal Zip Code 76092
City Area Code 682
Local Phone Number 237-7781
Entity Information, Former Legal or Registered Name n/a
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Ex Transition Period false
Common Stock [Member]  
Document Information [Line Items]  
Title of 12(b) Security Common Stock
Trading Symbol HSCS
Security Exchange Name NASDAQ
Warrant [Member]  
Document Information [Line Items]  
Title of 12(b) Security Warrants
Trading Symbol HSCSW
Security Exchange Name NASDAQ
EXCEL 5 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 6 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 7 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 3 24 1 false 2 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports hscs-20240130.htm hscs-20240130.xsd http://xbrl.sec.gov/dei/2023 false false JSON 11 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "hscs-20240130.htm": { "nsprefix": "hscs", "nsuri": "http://heartsciences.com/20240130", "dts": { "inline": { "local": [ "hscs-20240130.htm" ] }, "schema": { "local": [ "hscs-20240130.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 2, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 31, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 27 }, "report": { "R1": { "role": "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_7e414f57-2ced-4ff3-80e9-f03741f51819", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "hscs-20240130.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_7e414f57-2ced-4ff3-80e9-f03741f51819", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "hscs-20240130.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "terseLabel": "Document Information:", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "terseLabel": "Document Information", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "CIK", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInformationFormerLegalOrRegisteredName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInformationFormerLegalOrRegisteredName", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Information, Former Legal or Registered Name", "documentation": "Former Legal or Registered Name of an entity" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://heartsciences.com/20240130/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 12 0000950170-24-009160-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-009160-xbrl.zip M4$L#!!0 ( !1(/UB]5$]'V!8 ,Z^ 1 :'-CC0?@X.\WPY1<254D>?;V9[-C_$QDQG.1 M9)=O?S[L'YV<_/SW=W\Y&)10#:IFQ=N=05F.>MWN]?5UY]KNY.JR:X9AV+W! M.CMUI=Y-I%*1C.OB1UW3,@RO6Q?.5"T75G7KJN5TU61F M.U[6Z2%27+N&SK MITGVY9[J6!RQ8ES]YD[]&?BPM*V:W"SKU\1I0%7YYR_G']OJ69Z=5D.I$KZX MF2A5M[P=R2Y4I%E=E\NE1C U+/2S>*KW=8)SMZCIC7%:JJ4H"KM0NO/N+^0 @!+PFQR429G* M=P']_:!;_XE?#F7)"/9!Y7^JY.KMSE&>E3(KZ07@:X?P^M/;G5+>E%W->EWL MM-OT>A#EXI84Y6TJW^X,F;I,LAYA59G_5S(D_)\1-$O%VY\._!#?#V/4]RGTO MHHX#Z D\UZ06!10UY#"#J/ ,P)O>M;'&2S6[1%,6['T)!/R MYG=Y^ZS9OS. EQTO<$+KSDR[L[A6,I9*<\&[ Y1'O4*S/XQ&M'SJ(3>]W2E@ MD5.4!?J[@<+)($/1EFTZ-X4 @M'=3_>I/Q9YI?0G+6][#40:34?_8B)V A&: M@&#/A\45#F6QPRAG1NRYS(Q<-]YIFTJ-H_93(O!SG$A%]+3E0FX].OE]%B/S MC=ON"GF)1%-_%##8S2A->%)^DL,(AA )E&JUMM.(LEZ_9*7$-DP_CO< TH MD)AMC/L9EXWQ)I94;4O:S^T@W9FU6KQTCR/&]2[=Z\"4#&PN E=0X9L@P:3K MT5!:'O6\P&2"22% T[Y>(C_*A\,\TP6OGM"[LR*K.Z6FNJ#-YK5:K0IIF8]Z M3M QM.*;5!RUU6+HGA;)_\F>:8S*_:E6QKXNB]DP26][%X#_@IS*:W*>#UG6 M5HSRLLR'4!?G2%F:7&:]5,8E#E:,6-8.0G M0__,S^#[@GXY<&['=Q\:YZK6(70[QM4PN!V4ORE,QC8+@ MF2CXY^G)Q?%[TK\XO#CN'T2J^ZY_?/3/\Y.+D^,^.3Q]3X[_//KM\/378W)T M]NG32;]_!->#'=BQ\]WFNR\2C>)_S"M6L]O V M J':)VW(:=XQV;+ABMDPW# N?*[045B=+%4KSIS2C* MQ4K/,Z0(&'>HZW%0=5$L*/-M206H+H^;ON#"6I72^ZS]N^/:ZYL-Z GXAH+# M6@ZP&17LEMX"6%1F:\3G/UA6,75+;&./H'?ZL!X$PA9D4N+%2GD+)2M7W@\ O6\C?<->)7*#P_,B NUB9*Q"E>^0DXYTGVL7+ ME]W>++//[SQ(ATO0M7M\P\!JP96M%5&[HH05I#^2' .;@B09.2D+8OO>4W=\PN*?0,;^R/0U(P'5XNV/O?'O; M>JF(6ZRE#"=RF8@Y%7[$J&,%/@TBQZ26'P5"^IYM\A5I*1#\N1JA)DAP_P0H MZRBOLE+='N5BUFC%9 3<[BCE2.57V,]:K=4+><.*)YBHF^%#/7&=[5@XMLDX M=2V?4\?V)8U8 /^9IA<(WV81EZM9YP])*F'L2*HUKIG1I!E8W_NZ&9X(K,@+ MJ<%] _-!0AJY5D29*6S\Y 5.L)IUNV W)\T6*M<\NO9%M#QJ A".YSW#05P@ MTOU-E>BU7;AZDEG'HNQJT8QQMK-R(!7Y1Z620B0Z *=WN< \G1'E;];):Z\* M)!SN!M1G+AB[AFG1T+=CZLK( MY:9M2A;[JS&0#X50LBB:7Q^33)IKU):N:Y!S64AU)4F_5%*6>Z1?08_$]HRG M>CWC!;8V>8$WEW=6P2L+(H7?FG=L[O"0AR&5L0G^=&!S&H0.YND(Q_0M-_*< M>*6\\SN<"A\0]H>E4)$U($/-/1L M23WNR"ATK,AW5RNUM%=WICZK_"K11YVV\;;U!_K7;=W4D]M$R<*8[7JN:U/3 M B)WN&.!9 F0R$-/2,Z%/A"T0OK^G ,!I_^;C'0T>7W$ZWM&^)2@XS9:@ M0K/^N&OZ68%H2T8L)<-H]'&,X^\QPP!QQJ6S:CCF.[- Q\BYJAZYG@\SO,%"\U+-!+01C7 M;$IXP4.&Q-=#:\Q=FT=.3*45&]1A@.#0DHR*T#*8%426M*.7HO5C#ISU&6EJ M_3N+MD]]/S!7E7BZ509;9; A\4XCB*/08#XUP(>B#O@C- 12I\*0!O?<,+:M M<%4).^-[.C[ 'U)]E)T1Y)8LP:S2ZE('T, )&/K"B; P^KR"/MV-N4^U5@Y0$('TM>+X/W:"#Y M%WV\BHU&*A^I!%-"HOR&1#+-KY&8L!!IC 3T=Q*#> >[,"E(@ET((+(R)T4R MK-*293*OBO26%"!)BOA6MVP:Y!$ 6N_]-\>YU"3QN8)^%&'9;5L6@_;(K[$= MABD3S+,HGFN!K@!)Y.GT\#6-!6]MML*,5.BXMC^V!AYA/H3N^JP'NV.Z]R4& MAUXG<*QU&!C/32EI:XT]0:SW."/CP?5]'#4M-C(LA]M&Q"2UI;[#Q0:#08*E M$<>6ZWO2B0WKQ5G!?ZBD!)K#I*DJ:U* BKO[$E&>IQ$#SB]!_CQ=&BXG\Q"\ MR/VU;D-\^]5= :*:98+%GEXG,IHZGGM>@7!P++<1V7/'S8S_7E10#^ M)Q#$H/'3+2]N&B].UH@,FT6ZRXBFPZAI3?'BS+GX,2,Y-HVX*R@//8:A25<8+TZ:^*PDZD6\6%!?:H(VM3J+8ZFV3+EI M3 EK1?G48CVH*4U'4&LW>O,X%JWK;IGT:4P:NH*9/L@WSS1 8UK,IY%E21HY MD30]%@,+\Q4SZ4E15%)M6?6[8E4;B&>7/XY5F[JO=:OYP:/@W_"<=?@5+BIZ M;AQHRM51X\CX#"F-KR_24K^)9@'Y]%[!CHQ]7T#EOO/;IOO,AHZ[21&:^2BU M-8Y2?]NTNW7LM^@S61=XBWI]^1$?$([WX*Y&@RS')/DIUC^&_<-D;OYHI'6A M&&*DODWU=@AU=U>5D[>EJQ^8KC1!G3:WYFB))5O[#!0N] W?3+3RACI1FYB_ M[0:V*QR/QH'PJ8//%3 _F%6FELSH[ MO[ZCG>A+VK<'#58D5C:02CWF@5?O"?#8 _#8'L[D27OW+'X M5"IM-%>MM%9'HK_UC_I;TOQ^29-YP@J,(*)"X+%4YDH:!BS 4UZ^)0W?8<&= M -1S!6@;DM#I6'>"3J@0GWNF:ZDY!P[L*2L$^T\M9,DGIK[(DGS\>+2:LS$_ ML.KU \.U?!;2V)(!=2+F4!9ZC/IV:,N0F6$8W%&]CWI8Z*NHWN8-H.WYON]8 MMCFX!29CD%.F@7=2A2#6#"9IX',C-#TNW+MWB3V50M>H=O_8TN;W2YN&*Y@1 MF0'HW<"F3J W9P/T= M2:);PG5>*TSS"[D>2'V]V5S2:5(0F* $W%UBEL6ERJ_+ 6X3C3 1E15$R#C) MZIMXZ[0GPUWP%,'D!0*;["+'^?MXLLH.]W4&5-L&1@,*&N%5OIBS76\Y61&U M'OFZP7S?N LU:3[5^_C&Y5>1)ON"QSR^'9T=+Z&9!Y[4>6BX99>+"]OU;&%2 MD% .=3Q0QH$,?1H9)C_$QN/H42 O7KQJLHQJJ18^&EJIZ[F&0EV;G MA[[C/6+[^WLFOY/X'L&U!^)JH11,[F3=#T#&R53R$F13V MXQN^B=[2K%\61&K08Z6W./AU D,C[6N"D< M]" PG!6=LSJ^N1@CM'[)8^69(ZOBL@>33+[^O%[\\M[VEODM<&/@'OW:Z4!- M7*5+60>DP&L 8ZO'TFMV6S0Y#-OW4Q_M7CSXT-X,?'-OE[U$\ZXX(>BDE$-B M@]/<(:U!P"N__KF 6\>T2U%NV&5OK M$[Z':#2 <5$?,&R?Y]K#K=]OIQ$.JTO ";'TTU?V'KGW)1RRB_8,^F^ IL:X MUI_,_3< $)?)%1 $(ZDL0;206.5#;0&U)/(_%2Q#/$Y@!$J)8R2.>P(%Z#3J MX>KR\6B-B8B]E@-6[I&(H=%6C0";."1/\P(+HP0L--60=5YIPP]W6PL<9X_\ MU>@8ADE&3)$KEE823412#!B0^^X$SO'V['AX-"%QF'9!B6V@=56T%SE%%8R. M%ST)$*Y[Y%J">4K2'*Q 188 66W'_J=*5)W:";PU9$E6PC_ 'RQ6,JR&LY/_ MJSD]N:F%^-34_@5J?]:USR<]CV<,3 G34.-A]:%7,*5Q1&T,)PP/6FMK&#N_ MMU'09;S8\QP3F M6#:<---NP 2)I,S 0P,/!]L#>0JAC7]PC,S P#?Z:E]+WR0/-/6/*IT0Q=Y+ MJ P=0>U\*3%IU[]IO=PS>K43&OEQA.XIDE%#DT0]]X\2HD MM;C4SAHN\%1Q[2WOM1@OM+2^3M*T]7VQ6URR>;(97\LT+3KKEI$D117]&]QD M) S1FAD=K0+:*5_G52JPPPSKXZ7[95K+*S8:2: [/:"00,> A?I$/A:V,QV M#H-.0=VR3*9S?>,L>&.\:+&;9TG92/.%2B,IYP!!23IDM_J6B@P8JRB \> 3 M(*X6C@QC"%(5LM8RI ",EFU7>57J((*.)HP#IB_B$PTA2';.-,) T["BJ)3N MX0Y+:P0\6^Z+2M6"(BGN*29S7C+%\818G83_ *$V+,C'[D'K2$PB M9V@G 4M7)5Z2H:[A.[",\B]-I68Z'=*O^*"M0.]6(&@&3O-((6'_4E=7CV$ 1MVIHM-DX2OGS"%'$ ;7*8M,5,AUTS=YX)QXQ$^/KQ'&%"7P&)HII+Z!IA"WD.(>^/=.59HT5]4J9;V M&$].)K=2[34\63_/K/DVQV;722&1I;DLSTHC9U]G MQ[*33R*9UH=^YYSQ6.8>"T( M?"1A;CCZ'DV:,_A\Y;"\EP57R4B_8OFM4M$?(+O7+^^:\7X^@LXBE?R\5["L MH(4$JW_IPIB&LR*V?>5LN6ZI]DK0$\>+T:,[$9(WK\[VM!,'[K>\YQ0@8(%\ M9N#Z>VR2 Y8&K?;(MJV:BK@=EN5X=8R=L>JXI?&3##3C _",=-]S"^B/#ZG3L)^VQU?778-,O/5M\?'A^02Z.^Q?DX^$O M9^>'%V?G)\?]/7)R>K0PMKM(?&Q%QI:-MK!^Q["^&IOAJ?)VG1?WO@=3L+?) MRF:=P(\3D+O^L9)$(?7SF:)#(F!S?M*?2SN(XX?@Z-N8G'@U8HF#*;=#NEQPS ML?'P9Z(D+W-5O.2P^O--S0U^=&"C8^6;!=RJ-U@.NE$N;M_]Y: [*(?IN_\' M4$L#!!0 ( !1(/UA59*%#-@T ;! 1 :'-CY-I;I#N9FS:=))U[9SL['0RRS10C MK\")\^]7 @GS(LD86T!L^B$E(([.>?1V=!Z.\NF/Q=0#CQ '+O)/>X.#?@] MWT:.ZX]/>]_OC?/[B^OKWA]GKS[]PS# Y>?KK^ K? +G=N@^PDLWL#T4S#$$ M;^Z_O 5__^ON!MS;$SBUP"6RYU/HA\ DS"@W-GK$[GH3@C?T6T+=(W;X//>\9?'9]R[==RP/WO-)WX-JW#\"YYX$[^E8 M[F \2-T#F*9B\ Y"6(;0@N/8?C5FL)@9MGPM,7L*1-??"T][<_]_<\MR1"QT"L D1?S@Q FQ M$3[/8)#42O%;#+%W@/#8)(]-^IC6?&CTCXRC 7\3^O/I8?)6\@8IV#?A(H1^ MX X]:-!B$$>(!\8A;?CX=6)_ILJG(_9Z?V#^_>4F;EY>V'/]7V(%2?DCDSX> M6@'DQ>>!,;:L6?+&R J&46GV@"IYE" W:P5 ;0/QNC1) \R!2>!'91J&V8@ MD>6$(H#Z'\SX8;JHJ["/=.:0=+#$OD4!#X;>X/CXV(R>]LY> 1!U,GEB^C\*H<,G45[XX5Y2KZD"RNKF1 M48,^_4?6OM0RF%P282"6!E+B/IEY(3GQ\P ZM_Y9=#W#9-'R8P1OR WV,BNB M>-&V/'ONK?_>4BWI:^PF;[!L,_)1'T'LL6DP7<#"-GWS#HX NTPW=M*M7#\T M'7=JLC*FY7ED\HTD3# I/WTM!>0P>&Q:6D+FI%KNM0BWW#B1;ZB MGE(YNK5&4\OU-UE3] MAN$%FDYIOXG4"((YQ \4+'P[&BT'5$KEE:_4I'K$M_H;1 MHQN[]7FUE<5K4OD!6W1_?O\\'2)/H&/V>4U*D0VV:Q,'P1]_(:!@LN<6:"8H MU$0S7Y#+6_R GOQ5+9PJ69.B?V$W)-,,'1MSWXT=]$"@IKC<5I1<8P_RFMWX M>>%907 [N@^1_>LRL^0SG14%:^T"%V2RP99W32::Q9_P6=H!\N5J5?+!6EP[ M1 %WQ%KVZSSMEQ24E96O5>D[.'8#@ID?1DTG?]S9!7)6NC+9PC5W$QOA&8I# MT=$HNT!S,OD^*_56OU63 32"YGV;(!]*)^A"D9I4HY[+.8:6!,3,XYJ'4&I@ MDTT6O";3JLC#419O;-GXR\)T[?H"!>TM+M.<3T9\0SHVR#JE5+=8KIEMXUH; MQ@:VBA?H$>+S(75>[% TIC+/Z]IW07N.H\7>GEC^&$J65&&Q>AT7LH*/R<[O MWQ@]A1/2E#/+E[O?XM(U*7Q..I@34;2>-1:HF'U>*XJ?74^^UA2*-.%VL/_H M5#U8Y75DRM8\8 :'PP<:[E,,EJ1(S0LDI4\4"V+T6*02+4J9:')%/]^ OO'] M/AO")&BC.19&MF0QQ)_>, GEE(JG4I&]LX3M2LD#/R*)_V5,452RK6:0#48 M;^2VZ+1A56RT8I,0L8:=D@MBP2"6#"+1.LU2Q4XKFL1H5";S'8BD H0!EZO3 MGDRC4MAA[K:CR4A#@DFKK-D6[N/Y3 MO[Z2J/1FN!.A("L5Q&+UVY.-7&]FQE(6H,+:KGRZ[]2D^LJX^Y:F'RJJALFG M&(S?K -=+B7$Q^,\M2=;P#<2T@JH:NT\N*M(\;821_T]U0+ P0 M:=%G[JW7/SWP:]1=SDULR>^+90(B%%"I=8P&(P>&;X5O I=;A?5$><5/OD1>T\U<=& MQ*F8A48,&GM]A-%T1=8&KQF5H#1E/' =!I1-^^"&E.(UFS2H3#((-V8EF]FD M(<(4$:YYD;=L4E5YX@C75\)\BUKDFIIO(U4ZC'"A+O)- MS1M1*DDFW[]6,4Y-FB5+G>$V"$FE)A46)=1P90MD4AL&K"K-1K&UO,D0,4TO M=\)TF_025V1?FE99FG:3<4Z%!$R+-O/EM_%MVL +4W2245I@,!K=]RH2=Y*= MKXS):'Y!4J;SY+PW*9G1I!G")!^N>)$+:![Q8NI/%N8<%]"\PHJ$(*'?52 $ MVC \\VE"^:&9"?^W8=E/)P_EE_DDBIX^.2D5#"?0_\J?J90_:DX4@-=W#F7;@V(L7>=;,3B9CMRX[7W^^Y"X?&/!"LYQ?T#$K#9YWM%.' M7;V@@P%DCKCBNYSN+)W=/_GLA9Q\L(*TEJE:_QF(93[#D&G;T)F=& MM__\LHW/?4M'+[<2"IY9F,@S[(GK)6-@O>^*2X0#$2;#_+37[X$9&4 4_-/> M80_, Z(AFE&I=#XFMI&)@*Q>-S$@93X?;Q:B-;\B+,;M=A68LE% $:NP=ZB4 M_5(_A1Y#:+!K"*TWH'+QT%T%9=W!E(O&[BHLE3YC%74L!E#TAPMW"Z*JTW N M9,X!VG=XQ,%ZALY1AXZ0)V#PO._@43 4#*0/'4AY5H0A\UN'3 E2AH'UL0-+ M20 QF'[O8))23@RBXPXB"='%O>J]]QG5#!N':>=V'QO!E&/U.$A[[V!GN40. MR]Y[UD4^DT/3>=5K\:D^]8YSY%X+CLO2\M_AJ"P[.3/K4R95=.O/(( M];%F HBEQ^43T/)9<@XQN[HSY[ITH2YOK\O;VY&\O9IQ_DGF M,6ONU?;72[L,ODW0ZS+XJBHI_BB@H*.P6)?!UV7P=1E\709?E\%74M$N@Z_+ MX.LR^+9M4I?!UV7P=1E\70;?KF7P+2.IPN#S,C&"JN>$)[:' NB<]D(\A\N; MR _A(KSRHEY_V@O@F%[(8M=)(-CU0]-QITGHVO*V?\ JBSDJ8M:54>D74!E9 M7@#7-GM")&-[/H0&N0O)*%P>R+;U-,,VX^!$03%CFHG\;"F+L-5V\U8WG(Q) M6\[A>2$0L)"H#@R2>&N[L9 /@ZKS81SPU6%T<65H>.SGPL@D1H .#W]J*09I;T&'X MQ[8:OH*YT('%[VW%0DJ"Z$#AN*TH"%D5+?Y/"SU=*5>C!8 6>H!J#D@+"BWT M"%6TDA8,6N@79KDJ+5:WT"$LTF%:+&^M,UB6;=."2@O=0PEAI\7\%CJ)(BI0 MB^TM= I5/*,6#%KH$JXF+[7$B%KK&8JX4"T(M- U+%*L6BQOH3N88W"UF-U" M#U#,$9>SGF7@9#-L^&/^UZO(CZ$5P/CV)W,1."?6;.82U>@M=L/W49S!<_8J MOA/8$SBUSOX/4$L! A0#% @ %$@_6+U43T?8%@ SKX !$ M ( ! &AS8W,M,C R-# Q,S N:'1M4$L! A0#% @ %$@_6%5D MH4,V#0 !L$ !$ ( !!Q< &AS8W,M,C R-# Q,S N>'-D 64$L%!@ " ( ?@ &PD $! end XML 13 hscs-20240130_htm.xml IDEA: XBRL DOCUMENT 0001468492 us-gaap:WarrantMember 2024-01-30 2024-01-30 0001468492 2024-01-30 2024-01-30 0001468492 us-gaap:CommonStockMember 2024-01-30 2024-01-30 false 0001468492 8-K 2024-01-30 Heart Test Laboratories, Inc. TX 001-41422 26-1344466 550 Reserve Street, Suite 360 Southlake TX 76092 682 237-7781 n/a false false false false Common Stock HSCS NASDAQ Warrants HSCSW NASDAQ true false